101 related articles for article (PubMed ID: 23872372)
1. Nicotinic receptor partial agonists modulate alcohol deprivation effect in C57BL/6J mice.
Sajja RK; Rahman S
Pharmacol Biochem Behav; 2013 Sep; 110():161-7. PubMed ID: 23872372
[TBL] [Abstract][Full Text] [Related]
2. Varenicline and cytisine: two nicotinic acetylcholine receptor ligands reduce ethanol intake in University of Chile bibulous rats.
Sotomayor-Zárate R; Gysling K; Busto UE; Cassels BK; Tampier L; Quintanilla ME
Psychopharmacology (Berl); 2013 May; 227(2):287-98. PubMed ID: 23344555
[TBL] [Abstract][Full Text] [Related]
3. Cytisine modulates chronic voluntary ethanol consumption and ethanol-induced striatal up-regulation of ΔFosB in mice.
Sajja RK; Rahman S
Alcohol; 2013 Jun; 47(4):299-307. PubMed ID: 23601929
[TBL] [Abstract][Full Text] [Related]
4. Neuronal nicotinic receptor ligands modulate chronic nicotine-induced ethanol consumption in C57BL/6J mice.
Sajja RK; Rahman S
Pharmacol Biochem Behav; 2012 Jul; 102(1):36-43. PubMed ID: 22741175
[TBL] [Abstract][Full Text] [Related]
5. The effects of nicotine, varenicline, and cytisine on schedule-controlled responding in mice: differences in α4β2 nicotinic receptor activation.
Cunningham CS; McMahon LR
Eur J Pharmacol; 2011 Mar; 654(1):47-52. PubMed ID: 21172344
[TBL] [Abstract][Full Text] [Related]
6. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, selectively decreases ethanol consumption and seeking.
Steensland P; Simms JA; Holgate J; Richards JK; Bartlett SE
Proc Natl Acad Sci U S A; 2007 Jul; 104(30):12518-23. PubMed ID: 17626178
[TBL] [Abstract][Full Text] [Related]
7. Differential modulation of brain nicotinic acetylcholine receptor function by cytisine, varenicline, and two novel bispidine compounds: emergent properties of a hybrid molecule.
Peng C; Stokes C; Mineur YS; Picciotto MR; Tian C; Eibl C; Tomassoli I; Guendisch D; Papke RL
J Pharmacol Exp Ther; 2013 Nov; 347(2):424-37. PubMed ID: 23959137
[TBL] [Abstract][Full Text] [Related]
8. Development of an alcohol deprivation and escalation effect in C57BL/6J mice.
Melendez RI; Middaugh LD; Kalivas PW
Alcohol Clin Exp Res; 2006 Dec; 30(12):2017-25. PubMed ID: 17117967
[TBL] [Abstract][Full Text] [Related]
9. Modulation of ethanol consumption by genetic and pharmacological manipulation of nicotinic acetylcholine receptors in mice.
Kamens HM; Andersen J; Picciotto MR
Psychopharmacology (Berl); 2010 Mar; 208(4):613-26. PubMed ID: 20072781
[TBL] [Abstract][Full Text] [Related]
10. Lobeline and cytisine reduce voluntary ethanol drinking behavior in male C57BL/6J mice.
Sajja RK; Rahman S
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jan; 35(1):257-64. PubMed ID: 21111768
[TBL] [Abstract][Full Text] [Related]
11. Pre-clinical properties of the alpha4beta2 nicotinic acetylcholine receptor partial agonists varenicline, cytisine and dianicline translate to clinical efficacy for nicotine dependence.
Rollema H; Shrikhande A; Ward KM; Tingley FD; Coe JW; O'Neill BT; Tseng E; Wang EQ; Mather RJ; Hurst RS; Williams KE; de Vries M; Cremers T; Bertrand S; Bertrand D
Br J Pharmacol; 2010 May; 160(2):334-45. PubMed ID: 20331614
[TBL] [Abstract][Full Text] [Related]
12. Nicotinic ligands modulate ethanol-induced dopamine function in mice.
Sajja RK; Dwivedi C; Rahman S
Pharmacology; 2010; 86(3):168-73. PubMed ID: 20714207
[TBL] [Abstract][Full Text] [Related]
13. Effects of the nicotinic receptor partial agonists varenicline and cytisine on the discriminative stimulus effects of nicotine in rats.
LeSage MG; Shelley D; Ross JT; Carroll FI; Corrigall WA
Pharmacol Biochem Behav; 2009 Jan; 91(3):461-7. PubMed ID: 18817808
[TBL] [Abstract][Full Text] [Related]
14. Multiple nicotine training doses in mice as a basis for differentiating the effects of smoking cessation aids.
Cunningham CS; McMahon LR
Psychopharmacology (Berl); 2013 Jul; 228(2):321-33. PubMed ID: 23494230
[TBL] [Abstract][Full Text] [Related]
15. The nicotinic acetylcholine receptor partial agonist varenicline increases the ataxic and sedative-hypnotic effects of acute ethanol administration in C57BL/6J mice.
Kamens HM; Andersen J; Picciotto MR
Alcohol Clin Exp Res; 2010 Dec; 34(12):2053-60. PubMed ID: 20946306
[TBL] [Abstract][Full Text] [Related]
16. Differential cross-tolerance to the effects of nicotinic acetylcholine receptor drugs in C57BL/6J mice following chronic varenicline.
de Moura FB; McMahon LR
Behav Pharmacol; 2019 Aug; 30(5):412-421. PubMed ID: 30398980
[TBL] [Abstract][Full Text] [Related]
17. Alcohol deprivation effect is prolonged in the alcohol preferring (P) rat after repeated deprivations.
Rodd-Henricks ZA; McKinzie DL; Shaikh SR; Murphy JM; McBride WJ; Lumeng L; Li TK
Alcohol Clin Exp Res; 2000 Jan; 24(1):8-16. PubMed ID: 10656186
[TBL] [Abstract][Full Text] [Related]
18. Preclinical pharmacology of the alpha4beta2 nAChR partial agonist varenicline related to effects on reward, mood and cognition.
Rollema H; Hajós M; Seymour PA; Kozak R; Majchrzak MJ; Guanowsky V; Horner WE; Chapin DS; Hoffmann WE; Johnson DE; McLean S; Freeman J; Williams KE
Biochem Pharmacol; 2009 Oct; 78(7):813-24. PubMed ID: 19501054
[TBL] [Abstract][Full Text] [Related]
19. Varenicline modulates ethanol and saccharin consumption in adolescent male and female C57BL/6J mice.
Kamens HM; Silva C; Peck C; Miller CN
Brain Res Bull; 2018 Apr; 138():20-25. PubMed ID: 28778837
[TBL] [Abstract][Full Text] [Related]
20. Varenicline and cytisine diminish the dysphoric-like state associated with spontaneous nicotine withdrawal in rats.
Igari M; Alexander JC; Ji Y; Qi X; Papke RL; Bruijnzeel AW
Neuropsychopharmacology; 2014 Jan; 39(2):455-65. PubMed ID: 23966067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]